艾塞那肽
医学
胰高血糖素样肽1受体
内科学
回顾性队列研究
倾向得分匹配
2型糖尿病
利拉鲁肽
2型糖尿病
糖尿病
兴奋剂
受体
内分泌学
作者
Stephen S. Johnston,Hannah Nguyen,Eugene Felber,Katherine Cappell,J.W. Nelson,Bong-Chul Chu,Iftekhar Kalsekar
标识
DOI：10.1007/s12325-014-0166-0
摘要
Introduction
Greater adherence to medications has been broadly demonstrated to be associated with improved clinical outcomes. However, there is limited real-world evidence on adherence to glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy in patients with type 2 diabetes mellitus (T2DM).
科研通智能强力驱动
Strongly Powered by AbleSci AI
不配.
薰硝壤
Singularity
Leonardi
paparazzi221
可靠的书桃
一一
完美的天空
pcr163
HEIKU
寻道图强
咖啡豆
陈军
yufanhui
tuanheqi
pluto
8R60d8
sissiarno
坚强亦丝
Yziii
皖公网安备34019202002308
